FDA authorizes second COVID-19 antiviral pill, Merck's molnupiravir
Fox Business Flash top headlines for December 23
Check out what’s clicking on FoxBusiness.com.
The Food and Drug Administration (FDA) on Thursday authorized the use of Merck's molnupiravir pill for treating COVID-19, the second such emergency use authorization in two days.
Who can take the Merck COVID-19 pill?
The molnupiravir pill is cleared for use by adults 18 and older who have tested positive for COVID-19 and are at high risk of being hospitalized or dying.